AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 9.52 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.429 million which beat the analyst consensus estimate of $1.000 million by 42.90 percent. This is a 29.79 percent increase over sales of $1.101 million the same period last year.